Clinical Trial Update: Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating azeliragon in combination with stereotactic radiation therapy for brain metastases and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Azeliragon (Azeliragon)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Cancer, Metastasis | Phase 1, Phase 2 | Status: RECRUITING